Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.76 USD | -0.59% |
|
-4.31% | +3.18% |
13/06 | Collegium Pharmaceutical Says Nucynta Gets FDA Pediatric Exclusivity | MT |
07/06 | Jefferies Upgrades Collegium Pharmaceutical to Buy From Hold, Adjusts Price Target to $44 From $41 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.18% | 103.9Cr | |
+50.70% | 79TCr | |
+41.96% | 63TCr | |
-7.15% | 35TCr | |
+18.77% | 33TCr | |
+8.79% | 30TCr | |
+18.02% | 25TCr | |
+1.27% | 22TCr | |
+11.95% | 22TCr | |
+3.68% | 16TCr |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Insider Sell: Collegium Pharmaceutical